Cleared Traditional

K991459 - COPALIS EBV-M ANTIBODY ASSAY (FDA 510(k) Clearance)

May 1999
Decision
18d
Days
Class 1
Risk

K991459 is an FDA 510(k) clearance for the COPALIS EBV-M ANTIBODY ASSAY. This device is classified as a Antibody Igm, If, Epstein-barr Virus (Class I - General Controls, product code LJN).

Submitted by DiaSorin, Inc. (Columbia, US). The FDA issued a Cleared decision on May 14, 1999, 18 days after receiving the submission on April 26, 1999.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.3235.

Submission Details

510(k) Number K991459 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 26, 1999
Decision Date May 14, 1999
Days to Decision 18 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF

Device Classification

Product Code LJN — Antibody Igm, If, Epstein-barr Virus
Device Class Class I - General Controls
CFR Regulation 21 CFR 866.3235